2nd Quarter - Report

GARY BUEHLER for TEVA PHARMACEUTICALS USA, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Section 505(b)(2) new drug applications and exclusivity period.

Foreign entity interest: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issue(s) listed.

LobbyistCovered position, as disclosed
GARY BUEHLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.